Patent Assignment
Reel/Frame 059051/0297
Assignment of Assignor's Interest
Recorded: 2022-02-18
Pages: 12
Assignors
GILLIGAN, JAMES P.
Executed: 2017-07-13
MAURER, GEORGE R.
Executed: 2017-07-13
RAILKAR, ANIRUDDHA M.
Executed: 2017-07-13
BAUER, PHIL
Executed: 2017-07-13
Assignee
TARSA THERAPEUTICS, INC.
8 PENN CENTER, 1628 JOHN F. KENNEDY BOULEVARD, SUITE 1400, PHILADELPHIA, PENNSYLVANIA, 19103
Covered Property
(1)
Room Temperature Stable Oral Calcitonin Formulation
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 18, 2022
From: DAGGS, THOMAS A.; SHIELDS, PAUL P.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 059051/0284 →
Assignment of Assignor's Interest
Feb 18, 2022
From: TARSA THERAPEUTICS, INC.
To: TAURUS DEVELOPMENT COMPANY LLC
Reel/Frame 059051/0340 →
Assignment of Assignor's Interest
Jan 5, 2023
From: TAURUS DEVELOPMENT COMPANY LLC
To: PARK THERAPEUTICS, INC.
Reel/Frame 062287/0841 →
Corrective Assignment to Correct the the Assignment Previously Recorded Previously Recorded at Reel: 068713 Frame: 0499. Assignor(S) Hereby Confirms the Assignment.
Oct 24, 2024
From: TRIS PHARMA, INC.; PARK THERAPEUTICS, INC.
To: PROVIDENT BANK
Reel/Frame 070760/0864 →